These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25478766)

  • 1. Case histories in unresectable liver-dominant metastatic colorectal cancer.
    Sharma RA; Peeters M; Taïeb J
    Future Oncol; 2014 Nov; 10(15 Suppl):41-7. PubMed ID: 25478766
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective internal radiation therapy in untreated patients with unresectable liver dominant metastatic colorectal cancer.
    Şendur MA; Bilgin B; Akıncı MB; Dede DS; Özdemir N; Ulas A; Zengin N; Yalçın B
    Future Oncol; 2017 Feb; 13(3):205-207. PubMed ID: 27646504
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases.
    Aranda E; Aparicio J; Bilbao JI; García-Alfonso P; Maurel J; Rodríguez J; Sangro B; Vieitez JM; Feliu J
    Future Oncol; 2017 Oct; 13(23):2065-2082. PubMed ID: 28703622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-institution experience with selective internal radiation therapy (SIRT) for the treatment of unresectable colorectal liver metastases.
    O'Leary C; Greally M; McCaffrey J; Hughes P; Lawler LLP; O'Connell M; Geoghegan T; Farrelly C
    Ir J Med Sci; 2019 Feb; 188(1):43-53. PubMed ID: 29511912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of transarterial chemoembolization combined with systemic chemotherapy for patients with KRAS wild-type unresectable metachronous colorectal carcinoma with liver metastases.
    Yu Q; Zhang L; Fan S; Huang L; Wang X; Xindun C
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C205-C211. PubMed ID: 28230018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional transarterial chemoembolization combined with systemic therapy versus systemic therapy alone as second-line treatment for unresectable colorectal liver metastases: randomized clinical trial.
    Liu Y; Chang W; Zhou B; Wei Y; Tang W; Liang F; Chen Y; Yan Z; Lv M; Ren L; Xu J
    Br J Surg; 2021 Apr; 108(4):373-379. PubMed ID: 33611431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining systemic chemotherapy with chemoembolization in the treatment of unresectable hepatic metastases from colorectal cancer.
    You YT; Changchien CR; Huang JS; Ng KK
    Int J Colorectal Dis; 2006 Jan; 21(1):33-7. PubMed ID: 15942741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
    Boilève A; Maillard A; Wagner M; Dromain C; Laurent C; Dupont Bierre E; Le Sourd S; Audemar F; Ulusakarya A; Guerin-Meyer V; Smisth D; Pezzella V; De Baere T; Goere D; Gelli M; Taieb J; Boige V
    BMC Cancer; 2020 Jan; 20(1):74. PubMed ID: 32000724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination of neoadjuvant chemotherapy, cryotherapy and surgery in the treatment of unresectable colorectal liver metastases. Long-term results].
    Mariani F; Baldo S; Serventi A; Stella M; Malvezzi E; Meeus P; Kaemmerlen P; Negrier S; Sebban H; DeCian F; Rivoire M
    Tumori; 2003; 89(4 Suppl):107-8. PubMed ID: 12903563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic management of hepatic metastases from colorectal cancers].
    Lazorthes F; Navarro F; Ychou M; Delpero JR; Rougier P;
    Gastroenterol Clin Biol; 2003 Mar; 27 Spec No 2():B7. PubMed ID: 12637870
    [No Abstract]   [Full Text] [Related]  

  • 11. Current management of colorectal liver metastases.
    Martin LW; Warren RS
    Surg Oncol Clin N Am; 2000 Oct; 9(4):853-76; discussion 877-8. PubMed ID: 11008255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored Systemic Therapy for Colorectal Cancer Liver Metastases.
    Czauderna C; Luley K; von Bubnoff N; Marquardt JU
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.
    Giacchetti S; Itzhaki M; Gruia G; Adam R; Zidani R; Kunstlinger F; Brienza S; Alafaci E; Bertheault-Cvitkovic F; Jasmin C; Reynes M; Bismuth H; Misset JL; Lévi F
    Ann Oncol; 1999 Jun; 10(6):663-9. PubMed ID: 10442188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.
    Xu J; Qin X; Wang J; Zhang S; Zhong Y; Ren L; Wei Y; Zeng S; Wan D; Zheng S; ; ;
    J Cancer Res Clin Oncol; 2011 Sep; 137(9):1379-96. PubMed ID: 21796415
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic Arterial Therapy for First-Line Treatment of Unresectable Colorectal Liver Metastases: What We Know in the Wake of Two Recent Randomized Control Trials.
    Akinwande O; Martin RC
    Cardiovasc Intervent Radiol; 2017 Feb; 40(2):315-317. PubMed ID: 27650522
    [No Abstract]   [Full Text] [Related]  

  • 16. Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
    Gulec SA; Pennington K; Wheeler J; Barot TC; Suthar RR; Hall M; Schwartzentruber D
    Am J Clin Oncol; 2013 Oct; 36(5):455-60. PubMed ID: 22643569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer.
    Bartlett DL; Libutti SK; Figg WD; Fraker DL; Alexander HR
    Surgery; 2001 Feb; 129(2):176-87. PubMed ID: 11174711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of hepatic metastases of colorectal cancer.
    Smith JJ; D'Angelica MI
    Hematol Oncol Clin North Am; 2015 Feb; 29(1):61-84. PubMed ID: 25475573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Impact of FOLFOXIRI Aiming for Conversion Surgery in Unresectable Multiple Colorectal Liver Metastasis.
    Morine Y; Ikemoto T; Iwahashi S; Saito YU; Yamada S; Takasu C; Higashijima J; Imura S; Shimada M
    Anticancer Res; 2019 Sep; 39(9):5089-5096. PubMed ID: 31519620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
    Gibbs P; Gebski V; Van Buskirk M; Thurston K; Cade DN; Van Hazel GA;
    BMC Cancer; 2014 Dec; 14():897. PubMed ID: 25487708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.